Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

unknow

★ 5.0 · 41 reads

Request Code
ZLIB.IO18490945
Published
2022
Pages
1
Language
Unknown